肾移植术后以他克莫司及吗替麦考酚酯为基础的激素撤除方案的研究现状
Research Status of Steroid Withdrawal Regimens Based on Tacrolimus and Mycophenolate Mofetil after Kidney Transplantation
DOI: 10.12677/ACM.2023.133621, PDF,   
作者: 陈伯强, 张克勤：重庆医科大学附属第二医院泌尿肾病中心，重庆
关键词: 肾移植；激素；撤除；Kidney Transplantation； Steroid； Withdrawal
摘要: 目的：探索激素撤除方案对成人肾移植受者的影响，致力于为临床决策提供参考。方法：充分检索近20年国内外以他克莫司及吗替麦考酚酯为基础的激素撤除免疫抑制维持方案的临床随机对照研究，评估激素撤除对肾移植受者的有效性及安全性。结果：大部分研究结果显示肾移植术后无激素或早期撤除激素对受者安全且有效，但各移植中心并未达成一致意见。结论：肾移植术后撤除激素利大于弊，但仍需充分评估患者具体情况，制定个体化的免疫抑制维持方案。
Abstract: Objective: To explore the effect of steroid withdrawal on adult renal transplant recipients, in a bid to provide reference for clinical decision-making. Methods: We fully searched the clinical random-ized controlled studies of steroid withdrawal immunosuppression maintenance regimens based on tacrolimus and mycophenolate mofetil in the past 20 years at home and abroad to evaluate the ef-fectiveness and safety of steroid withdrawal in adult renal transplant recipients. Results: Most of the research results show that steroid-free or early steroid withdrawal after kidney transplantation is safe and effective for recipients, but the transplantation centers have not reached an agreement. Conclusions: The advantages of steroid withdrawal after kidney transplantation outweigh the dis-advantages, but it is still necessary to fully evaluate the specific situation of recipients and formu-late individualized immunosuppression maintenance regimen.
文章引用：陈伯强, 张克勤. 肾移植术后以他克莫司及吗替麦考酚酯为基础的激素撤除方案的研究现状[J]. 临床医学进展, 2023, 13(3): 4328-4334. https://doi.org/10.12677/ACM.2023.133621

参考文献

[1] Zhang, L., Wang, F., Wang, L., et al. (2012) Prevalence of Chronic Kidney Disease in China: A Cross-Sectional Survey. The Lancet, 379, 815-822. [Google Scholar] [CrossRef] 
[2] 《中国腹膜透析管理现状白皮书》项目组. 中国腹膜透析管理现状白皮书[J]. 中华肾脏病杂志, 2022(12): 1076-1104.
[3] Wolfe, R.A., Ashby, V.B., Milford, E.L., et al. (1999) Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Trans-plantation, and Recipients of a First Cadaveric Transplant. The New England Journal of Medicine, 341, 1725-1730. [Google Scholar] [CrossRef] 
[4] Ekberg, H., Tedesco-Silva, H., Demirbas, A., et al. (2007) Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. The New England Journal of Medicine, 357, 2562-2575. [Google Scholar] [CrossRef] 
[5] Locke, J.E. (2018) Handbook of Kidney Transplantation. Sixth Edition G. M. Danovitch (Editor) Wolters Kluwar, 2017, 606pp. ISBN: 9781496326157. American Journal of Transplantation, 18, 1820. [Google Scholar] [CrossRef] 
[6] Rike, A.H., Mogilishetty, G., Alloway, R.R., et al. (2010) Cardiovascular Risk, Cardiovascular Events, and Metabolic Syndrome in Renal Transplantation: Comparison of Early Steroid Withdraw-al and Chronic Steroids. Clinical Transplantation, 22, 229-235. [Google Scholar] [CrossRef] [PubMed]
[7] Veenstra, D.L., Best, J.H., Hornberger, J., et al. (1999) In-cidence and Long-Term Cost of Steroid-Related Side Effects after Renal Transplantation. American Journal of Kidney Diseases, 33, 829-839. [Google Scholar] [CrossRef] 
[8] Rangaswami, J., Mathew, R.O., Parasuraman, R., et al. (2019) Cardiovascular Disease in the Kidney Transplant Recipient: Epidemiology, Diagnosis and Management Strategies. Nephrology Dialysis Transplantation, 34, 760-773. [Google Scholar] [CrossRef] [PubMed]
[9] De Lucena, D.D. and Rangel, É.B. (2018) Glucocorticoids Use in Kidney Transplant Setting. Expert Opinion on Drug Metabolism & Toxicology, 14, 1023-1041. [Google Scholar] [CrossRef] [PubMed]
[10] Stoumpos, S., Jardine, A.G. and Mark, P.B. (2015) Cardio-vascular Morbidity and Mortality after Kidney Transplantation. Transplant International, 28, 10-21. [Google Scholar] [CrossRef] [PubMed]
[11] Ojo, A.O. (2006) Cardiovascular Complications after Renal Transplantation and Their Prevention. Transplantation, 82, 603-611. [Google Scholar] [CrossRef] [PubMed]
[12] Knight, S.R. and Morris, P.J. (2010) Steroid Avoidance or Withdrawal after Renal Transplantation Increases the Risk of Acute Rejection but Decreases Cardiovascular Risk. A Me-ta-Analysis. Transplantation, 89, 1-14. [Google Scholar] [CrossRef] 
[13] Taber, D.J., Hunt, K.J., Gebregziabher, M., et al. (2017) A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology, 12, 131-139. [Google Scholar] [CrossRef] 
[14] Thomusch, O., Wiesener, M., Opgenoorth, M., et al. (2016) Rab-bit-ATG or Basiliximab Induction for Rapid Steroid Withdrawal after Renal Transplantation (Harmony): An Open-Label, Multicentre, Randomised Controlled Trial. The Lancet, 388, 3006-3016. [Google Scholar] [CrossRef] 
[15] Rhen, T. and Cidlowski, J.A. (2005) Antiinflammatory Ac-tion of Glucocorticoids—New Mechanisms for Old Drugs. The New England Journal of Medicine, 353, 1711-1723. [Google Scholar] [CrossRef] 
[16] 王振, 付迎欣. 糖皮质激素在肾移植中的应用[J]. 实用器官移植电子杂志, 2014(2): 83-86.
[17] Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. American Journal of Transplantation, 9, S1-S155. [Google Scholar] [CrossRef] [PubMed]
[18] Webster, A.C., Woodroffe, R.C., Taylor, R.S., et al. (2005) Tacrolimus versus Ciclosporin as Primary Immunosuppression for Kidney Transplant Recipients: Meta-Analysis and Meta-Regression of Randomised Trial Data. BMJ, 331, 810. [Google Scholar] [CrossRef] 
[19] Knight, S.R., Russell, N.K., Barcena, L., et al. (2009) Myco-phenolate Mofetil Decreases Acute Rejection and May Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review. Transplantation, 87, 785-794. [Google Scholar] [CrossRef] 
[20] Ekberg, J., Baid-Agrawal, S., Jespersen, B., et al. (2021) A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipi-ents. Kidney International Reports, 7, 259-269. [Google Scholar] [CrossRef] [PubMed]
[21] Van Sandwijk, M.S., De Vries, A.P.J., Bakker, S.J.L., et al. (2018) Early Steroid Withdrawal Compared with Standard Immunosuppression in Kidney Transplantation—Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial. Transplantation Direct, 4, e354. [Google Scholar] [CrossRef] 
[22] Krämer, B.K., Klinger, M., Vítko, Š., et al. (2012) Tacroli-mus-Based, Steroid-Free Regimens in Renal Transplantation: 3-Year Follow-Up of the ATLAS Trial. Transplantation, 94, 492-498. [Google Scholar] [CrossRef] 
[23] Mourad, G., Glyda, M., Albano, L., et al. (2017) Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Pro-longed-Release Tacrolimus-Based Immunosuppression with 2 Different Corticosteroid Minimization Strategies: ADVANCE, a Randomized Controlled Trial. Transplantation, 101, 1924-1934. [Google Scholar] [CrossRef] 
[24] Woodle, E.S., First, M.R., Pirsch, J., et al. (2008) A Prospec-tive, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 Day) Corticosteroid Cessation versus Long-Term, Low-Dose Corticosteroid Therapy. Annals of Surgery, 248, 564-577. [Google Scholar] [CrossRef] 
[25] Woodle, E.S., Gill, J.S., Clark, S., et al. (2021) Early Corti-costeroid Cessation vs Long-Term Corticosteroid Therapy in Kidney Transplant Recipients: Long-Term Outcomes of a Randomized Clinical Trial. JAMA Surgery, 156, 307-314. [Google Scholar] [CrossRef] [PubMed]
[26] Nagib, A.M., Abbas, M.H., Abu-Elmagd, M.M., et al. (2015) Long-Term Study of Steroid Avoidance in Renal Transplant Patients: A Single-Center Experience. Transplantation Pro-ceedings, 47, 1099-1104. [Google Scholar] [CrossRef] [PubMed]
[27] Gheith, O.A., Nematalla, A.H., Bakr, M.A., et al. (2011) Steroid Avoidance Reduce the Cost of Morbidities after Live-Donor Renal Allotransplants: A Prospective, Randomized, Controlled Study. Experimental and Clinical Transplantation, 9, 121-127.
[28] Garcia, V.D., Carvalho, D.B.M., Gon-calves, R.T., et al. (2008) Corticosteroid Reduction with Tacrolimus (CORRETA) TRIAL: A Prospective Brazilian Mul-ticenter, Randomized Trial of Early Corticosteroid Reduction versus Regular Corticosteroid Dosage Maintenance on a Tacrolimus (Prograf) and Mycophenolate Mofetil (Cellcept) Immunosuppression Regimen in Kidney Transplant Recipi-ents: Interim Analysis. Transplantation Proceedings, 40, 689-692. [Google Scholar] [CrossRef] [PubMed]
[29] Hernández, D., Alonso-Titos, J., Vázquez, T., et al. (2021) Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant Patients. Journal of Clinical Medicine, 10, 2005. [Google Scholar] [CrossRef] [PubMed]
[30] Vazquez, T., Alonso-Titos, J., Gamez, J.P., et al. (2018) Effect of Ster-oid Withdrawal on the Appearance of de Novo Donor-Specific HLA Antibodies in Kidney Transplant Recipients: A Prospective, Randomized, Controlled, Parallel Group Study. Preliminary Results. Transplantation, 102, S203. [Google Scholar] [CrossRef] 
[31] Oh, C.K., Kim, S.J., Kim, J.H., et al. (2012) Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients. Journal of Korean Medical Science, 27, 337-342. [Google Scholar] [CrossRef] [PubMed]
[32] Zhu, Q.G., Zhao, Y.K., Liu, W., et al. (2008) Two-Year Observa-tion of a Randomized Trial on Tacrolimus-Based Therapy with Withdrawal of Steroids or Mycophenolate Mofetil after Renal Transplantation. Chinese Medical Sciences Journal, 23, 244-248. [Google Scholar] [CrossRef] 
[33] Desai, V.C.A., Ferrand, Y., Cavanaugh, T.M., et al. (2017) Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Trans-plantation: Results from Discrete Event Simulation. Medical Decision Making, 37, 827-843. [Google Scholar] [CrossRef] 
[34] Alonso-Titos, J., Ruiz-Esteban, P., Palma, E., et al. (2017) De Novo Donor-Specific HLA Antibodies after Steroid Withdrawal in Kidney Transplant Recipients: A Prospective, Ran-domized, Controlled, Parallel Group Study. Preliminary Results. Transplant International, 30, 243.
[35] Hardinger, K.L., Brennan, D.C. and Klein, C.L. (2013) Selection of Induction Therapy in Kidney Transplantation. Transplant Internation-al, 26, 662-672. [Google Scholar] [CrossRef] [PubMed]

为你推荐